+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biocatalysts Market - Global Outlook & Forecast 2022-2027

  • PDF Icon


  • 238 Pages
  • December 2022
  • Region: Global
  • Arizton
  • ID: 5699664
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global biocatalysts market is expected to grow at a CAGR of 6.67% during 2021-2027. Biocatalysts are substances, specifically enzymes, that activate or speed up a biochemical reaction. Biocatalysts are used in chemical synthesis in various industries (such as pharmaceuticals, food & beverages, animal nutrition, household, and others). In the pharmaceutical industry, biocatalysts help in manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments.

Increasing demand for biobased products drives the biocatalysts market. Due to emerging technology, sustainability is growing all over the world. In the pharmaceutical industry, companies have started using biobased drugs to improve the quality of products, making the pharmaceutical biocatalysts market grow rapidly. Thus, top companies follow the expansion strategy for acquiring a greater biocatalysts market share. The food & beverages industry is rising due to the increasing consumption of food & beverages, thus increasing the demand for biocatalysts in the global industry.


Increase in Food Consumption Due to Growth in Population

  • The food industry includes four major sectors - producers, marketers, processors, and farm services. During the Covid 19, the demand for food supplies increased, resulting in the food industry's growth. Enzymes are used in the food industry as a preservative, the best substitute for chemical preservatives. They improve the quality of products such as starch, fruit juices, cheese, animal feed, and beer & wine. From the application perspective, the demand for animal feed is increasing due to higher poultry, meat, and dairy consumption.

Increasing Demand from Pharmaceutical Industry

  • The pharmaceutical industry’s revenue is increasing yearly due to increasing demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues.
  • The lowering of regulatory barriers for new drugs in the US causes an increased demand for pharma sector products globally. During the Covid-19 pandemic, the highest demand for pharmaceutical products was observed. The demand for new drugs is still high owing to the recurrence of new variants of Covid-19 in various countries. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of Covid-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And with a growing global pharmaceutical industry, the biocatalysts market is also growing.


Technical Barriers Affecting Industry

Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, biocatalysts play an important role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of biocatalysts. The process is time-consuming and requires more catalysts to fulfilling the chemical reaction process. For the biocatalysts manufacturing process, specific conditions such as new substrate, new concentration, and other conditions are required which are not found easily in nature. Thus, increasing the cost of producing the biocatalysts.



  • Carbohydrases is the largest segment by type in the global biocatalysts market and is expected to reach USD 231.03 million by 2027. Carbohydrases are mainly used in the food industry as biocatalysts. Most of these biocatalysts used in the food industry are produced from fungi, yeast, and bacteria. Carbohydrases are used in milk products as digestion agents to reduce milk lactose. These are further classified into alpha, beta amylases, cellulases, glucosidase, pectinases, mannanases, galacto, and pullulanase.
  • The global proteases-based biocatalysts market was valued at USD 134.40 million in 2021 and is the second largest industry by type segment. The proteases are used in the cleaning, leather, and dairy industries. Based on the catalysis mechanism, the proteases are classified into further classes glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
  • Lipases are used in the catalysis of fats, which helps reduce their food content. These are derived from animal and plant enzymes used in various biological processes, which are used for inflammation, diet, and increasing metabolism. The lipases segment is expected to grow at a CAGR of 5.49% during the forecast period. These are used in esters and have high scope in biofuels. The increased demand for biofuels is due to the increasing prices of crude oil, which further increases the demand for lipases in the biocatalysts markets.

Segmentation by Type

  • Carbohydrases
  • Proteases
  • Polymerases & Nucleases
  • Lipases
  • Phytases
  • Other


  • The global biocatalysts market by end-use is categorized as pharmaceutical, food & beverages, animal nutrition, household, and others. The pharmaceutical is the largest segment by end-use and is expected to cross USD 215.42 million by 2027. Due to growth in the global population, the demand for pharmaceutical products is increasing. Due to which people are becoming more health conscious, pharmaceutical companies are focusing on increasing the bio-based content in drug formulations. In the pharmaceutical industry, biocatalysts are used for molecular biology, extraction of medically important compounds, diagnostic procedures, chemical pharmaceutical manufacturing, and deficiencies supplements.
  • The food & beverages segment is growing with a CAGR of 6.31 % during the forecast period and is the second largest segment by end-use. Biocatalysts have been used for hundreds of years in the food & beverages industry. Commercial biocatalysts are produced from microbial, plants, and animals. There is a massive demand for bakery biocatalysts in the industry for extending shelf life, mainly in Europe and North America. Biocatalyst manufacturing companies are developing new designs to improve bakery food quality.

Segmentation by End Use

  • Pharmaceutical
  • Food & Beverages
  • Animal Nutrition
  • Household
  • Others


North America dominates the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. The region is the leading market for biocatalysts because of its rapidly developing infrastructure, readily increasing population, and growing demand from various industries such as food & beverage, pharmaceutical, animal nutrition, and household. The US and Canada are the two major countries dominating North America’s biocatalyst market. The demand for biocatalysts in North America's pharmaceutical industry is increasing with the rise in pharma products and the presence of the world-leading ten pharmaceutical companies in the US.

APAC biocatalysts market is the second largest industry globally and is expected to grow the highest CAGR during the forecast period. With the changing technology & innovations in food & beverages, the demand for biocatalysts is increasing. Increasing health expenditure, increasing health consciousness, increasing new diseases, and others are the key factors for the growing pharmaceutical market, further contributing to the Asia Pacific industry.

Germany, Italy, France, and Spain are the major countries in the European biocatalyst market. The increasing consumption of biocatalysts is attributed to the rising per capita income in European countries. High spending on healthy food, attributed to people's health-conscious habits, and growing demand for food & beverages biocatalysts are significant market drivers in Europe.

Segmentation by Geography

  • APAC
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
  • Latin America
  • Brazil
  • Mexico
  • Rest Of Latin America
  • Middle East & Africa
  • South Africa
  • South Arabia
  • Rest of the Middle East & Africa


Some key players in the global biocatalysts market include DuPont (U.S.), AB Enzymes (Germany), BASF SE (Germany), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies such as expansion, acquisitions, new product development, joint ventures, and others to increase their revenues in the biocatalysts market. Furthermore, other prominent companies such as Amano Enzymes (Japan), Dyadic International (U.S.), Codexis (U.S.), and others have invested considerable capital in R&D to develop biocatalysts-based products that will appeal to the customers. Therefore, these other prominent companies are giving tough competition to major companies.

The major companies follow a merger and acquisition strategy, giving them a competitive advantage to boost their market share. The key vendors have undertaken various strategies to grow in the global biocatalysts market. The growth in sustainable processes and innovations has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable biocatalysts products.

Key Vendors

  • DuPont
  • DSM
  • AB Enzymes
  • Novozymes

Other Prominent Vendors

  • Chr Hansen Holding A/S
  • Codexis
  • Dyadic International Inc.
  • Amano Enzymes
  • Biocatalysts
  • Nature Bioscience Pvt Ltd.
  • Johnson Matthey
  • Advanced Enzymes Technologies
  • Zymtronix, Inc.
  • Nutritech
  • Hoffmann-La Roche Ltd (Roche CustomBiotech)
  • Aumenzymes
  • The Soufflet Group
  • Iosynth

Key Developments In The Global Biocatalysts Market:

  • In 2021 Novozymes bought majority stakes in the Mumbai (India) based Synergia Life Sciences company, a global leader in the microbiome therapeutic and vitamin k2-7 manufacturer and supplier.
  • DSM acquired the U.S.-based First Choice Ingredients company, a manufacturer of dairy-based flavorings. This deal gives the company fermentation and biotechnology solutions.


1. What is the revenue from the global biocatalysts market?
2. What is the growth rate of the biocatalysts market?
3. Who are the key players in the global biocatalysts market?
4. What is the projected biocatalysts market by 2027?
5. What are the key driving factors in the global biocatalysts market?
6. Which region dominates the global biocatalysts Market?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Premium Insights
6.1 Introduction
6.2 Market Synopsis
6.2.1 Enabler
6.2.2 Opportunities
6.2.3 Restraint
6.3 Segment Review
6.3.1 End-Users
6.3.2 Type
6.4 Geography
6.5 Companies and Strategies
7 Market at a Glance
8 Introduction
8.1 Overview
8.2 Value Chain Analysis
8.2.1 Raw Materials
8.2.2 Biocatalyst Manufacturer
8.2.3 Distributor
8.2.4 Application
8.3 Macroeconomic Factors
8.3.1 Pharmaceutical & Biopharmaceutical Industries
8.3.2 Food & Beverages Industry
9 Market Opportunities & Trends
9.1 Increasing Demand from Pharmaceutical Industry
9.2 Soaring Demand for Biofuel
9.3 Adoption of Sustainability Standards to Improve Productivity & Profitability
9.4 Increasing Use of Cleaning Products
10 Market Growth Enablers
10.1 Increase in Food Consumption Due to Growing Population
10.2 Rise in Demand for Plant-Based Products
11 Market Growth Restraints
11.1 Technical Barriers Affecting Biocatalysts Market
11.2 High Cost & Lack of Awareness of Biobased Products
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Carbohydrases
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Proteases
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Polymerases & Nucleases
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
13.6 Lipases
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Market by Geography
13.7 Phytases
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Market by Geography
13.8 Others
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.8.3 Market by Geography
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Pharmaceutical
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Food & Beverages
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Animal Nutrition
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography
14.6 Household
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Market by Geography
14.7 Others
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Market by Geography
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Type
16.3.1 Market Size & Forecast
16.4 End-User
16.4.1 Market Size & Forecast
16.5 Key Countries
16.6 US
16.6.1 Market Size & Forecast
16.7 Canada
16.7.1 Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Type
17.3.1 Market Size & Forecast
17.4 End-User
17.4.1 Market Size & Forecast
17.5 Key Countries
17.6 Germany
17.6.1 Market Size & Forecast
17.7 France
17.7.1 Market Size & Forecast
17.8 Italy
17.8.1 Market Size & Forecast
17.9 Spain
17.9.1 Market Size & Forecast
17.10 Rest of Europe
17.10.1 Market Size & Forecast
18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Type
18.3.1 Market Size & Forecast
18.4 End-User
18.4.1 Market Size & Forecast
18.5 Key Countries
18.6 China
18.6.1 Market Size & Forecast
18.7 India
18.7.1 Market Size & Forecast
18.8 Japan
18.8.1 Market Size & Forecast
18.9 South Korea
18.9.1 Market Size & Forecast
18.10 Rest of Apac
18.10.1 Market Size & Forecast
19 Middle East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Type
19.3.1 Market Size & Forecast
19.4 End-User
19.4.1 Market Size & Forecast
19.5 Key Countries
19.6 Saudi Arabia
19.6.1 Market Size & Forecast
19.7 South Africa
19.7.1 Market Size & Forecast
19.8 Rest of Middle East & Africa
19.8.1 Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Type
20.3.1 Market Size & Forecast
20.4 End-User
20.4.1 Market Size & Forecast
20.5 Key Countries
20.6 Brazil
20.6.1 Market Size & Forecast
20.7 Mexico
20.7.1 Market Size & Forecast
20.8 Rest of Latin America
20.8.1 Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
22 Key Company Profiles
22.1 Dupont
22.1.1 Business Overview
22.1.2 Financial Overview
22.1.3 Product Offerings
22.1.4 Key Strategies
22.1.5 Key Strengths
22.1.6 Key Opportunities
22.2 Basf Se
22.2.1 Business Overview
22.2.2 Financial Overview
22.2.3 Product Offerings
22.2.4 Key Strategies
22.2.5 Key Strengths
22.2.6 Key Opportunity
22.3 Dsm
22.3.1 Business Overview
22.3.2 Financial Overview
22.3.3 Product Offerings
22.3.4 Key Strategy
22.3.5 Key Strengths
22.3.6 Key Opportunity
22.4 Ab Enzymes
22.4.1 Business Overview
22.4.2 Financial Overview
22.4.3 Product Offerings
22.4.4 Key Strategies
22.4.5 Key Strengths
22.4.6 Key Opportunities
22.5 Novozymes
22.5.1 Business Overview
22.5.2 Financial Overview
22.5.3 Product Offerings
22.5.4 Key Strategies
22.5.5 Key Strengths
22.5.6 Key Opportunities
23 Other Prominent Vendors
23.1 Chr. Hansen Holding A/S
23.1.1 Company Overview
23.1.2 Business Overview
23.1.3 Product Offerings
23.2 Codexis
23.2.1 Company Overview
23.2.2 Business Overview
23.2.3 Product Offerings
23.3 Dyadic International Inc.
23.3.1 Company Overview
23.3.2 Business Overview
23.3.3 Product Offerings
23.4 Amano Enzyme Inc.
23.4.1 Company Overview
23.4.2 Business Overview
23.4.3 Product Offerings
23.5 Biocatalysts
23.5.1 Company Overview
23.5.2 Business Overview
23.5.3 Product Offerings
23.6 Nature Bioscience
23.6.1 Company Overview
23.6.2 Business Overview
23.6.3 Product Offerings
23.7 Johnson Matthey
23.7.1 Company Overview
23.7.2 Business Overview
23.7.3 Product Offerings
23.8 Advanced Enzymes Technologies
23.8.1 Company Overview
23.8.2 Business Overview
23.8.3 Product Offerings
23.9 Zymtronix, Inc.
23.9.1 Company Overview
23.9.2 Product Offerings
23.10 Nutritech
23.10.1 Company Overview
23.10.2 Product Offerings
23.11 F. Hoffmann-La Roche Ltd (Roche Custombiotech)
23.11.1 Company Overview
23.11.2 Business Overview
23.11.3 Product Offerings
23.12 Aumenzymes
23.12.1 Company Overview
23.12.2 Product Offerings
23.13 Soufflet Group
23.13.1 Company Overview
23.13.2 Business Overview
23.13.3 Product Offerings
23.14 Iosynth
23.14.1 Company Overview
23.14.2 Business Overview
23.14.3 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market by End-User
25.1.1 Pharmaceutical
25.1.2 Food & Beverage
25.1.3 Animal Nutrition
25.1.4 Household
25.1.5 Others
25.2 Market by Type
25.2.1 Carbohydrases
25.2.2 Proteases
25.2.3 Polymerases & Nucleases
25.2.4 Lipases
25.2.5 Phytases
25.2.6 Other
26 Geography
26.1 North America
26.1.1 Type
26.1.2 End-User
26.2 Europe
26.2.1 Type
26.2.2 End-User
26.3 Apac
26.3.1 Type
26.3.2 End-User
26.4 Middle East & Africa
26.4.1 Type
26.4.2 End-User
26.5 Latin America
26.5.1 Type
26.5.2 End-User
27 Appendix
27.1 Abbreviations

Companies Mentioned

  • DuPont
  • DSM
  • AB Enzymes
  • Novozymes
  • Chr Hansen Holding A/S
  • Codexis
  • Dyadic International Inc.
  • Amano Enzymes
  • Biocatalysts
  • Nature Bioscience Pvt Ltd.
  • Johnson Matthey
  • Advanced Enzymes Technologies
  • Zymtronix, Inc.
  • Nutritech
  • Hoffmann-La Roche Ltd (Roche CustomBiotech)
  • Aumenzymes
  • The Soufflet Group
  • Iosynth


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



Table Information